EUVIMEDEUVIMED entdecken
Crossref

Can amylin weight-loss drugs compete in a world of GLP-1s?

Aayushi Pratap

C&EN Global Enterprise · 20.04.2026 · 104 (5) · 52-57

DOI: 10.1021/cen-10405-feature3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift C&EN Global Enterprise, online erschienen am 20.04.2026. Verfasst von Aayushi Pratap.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Pratap, A. (2026). Can amylin weight-loss drugs compete in a world of GLP-1s?. C&EN Global Enterprise, 104(5), 52-57. https://doi.org/10.1021/cen-10405-feature3

Vancouver

Pratap A. Can amylin weight-loss drugs compete in a world of GLP-1s?. C&EN Global Enterprise. 2026;104(5):52-57. doi:10.1021/cen-10405-feature3

BibTeX
@article{Pratap2026,
  author = {Pratap, Aayushi},
  title = {Can amylin weight-loss drugs compete in a world of GLP-1s?},
  journal = {C&EN Global Enterprise},
  year = {2026},
  volume = {104},
  number = {5},
  pages = {52--57},
  doi = {10.1021/cen-10405-feature3}
}
Kostenlos starten →